腫瘍学者が,HIV検査のルーティン・オプト・アウトに賛成する時期が来たのか?
Elizabeth Y Chiao1, Bruce J Dezube, Susan E Krown
1Department of Medicine, Baylor College of Medicine, and Health Services Research and Development, Department of Veterans Affairs Medical Center, Houston, Texas 77030, USA. echiao@bcm.edu
JAMA
|July 20, 2010
まとめ
がん患者のためのルーティン・オプトアウトヒト免疫不全ウイルス (HIV) 検査は推奨されます. このアプローチは,診断された患者のがん治療中にHIVの適切な管理を可能にすることで,結果を改善することができます.
科学分野:
- 腫瘍学 腫瘍学
- 感染症 感染症は感染症です.
- 公衆衛生は公衆衛生である.
背景:
- ヒト免疫不全ウイルス (HIV) の個人は,悪性腫瘍を発症するリスクが高くなります.
- 通常のHIV検査は,すべての医療機関でのオプトアウトスクリーニングに関するCDCの勧告にもかかわらず,がん患者に対する標準的なケアではありません.
- 現在のオプトアウトのHIV検査は,主に特定の集団を対象とし,腫瘍学のようなより広範な臨床環境での実施は限られている.
研究 の 目的:
- 癌患者に対するHIV検査のルーティン・オプトアウトを支える根拠と証拠を提示する.
- 癌治療中のHIV管理を改善することにより,臨床結果を向上させるため,オプトアウトのHIV検査の可能性を議論する.
主な方法:
- 癌患者のHIV検査のオプトアウトの背景,根拠,および証拠のレビュー.
- 簡易なHIV管理による臨床成果の改善に関する証拠の検討.
主要な成果:
- ヒト免疫不全ウイルス (HIV) に感染した個人は悪性腫瘍のリスクが高い.
- 推奨にもかかわらず,米国では,通常のオプトアウトHIV検査は広く実施されていません.
- オプトアウトテストは,特定の設定で潜在性を示していますが,より広範なアプリケーションが必要です.
結論:
- ルーティン・オプト・アウト・HIV検査は,がん患者の標準的なケアとして考慮されるべきです.
- オプトアウトのHIV検査の実施は,がん治療中にHIVのより良い管理につながる可能性があります.
- この戦略は,HIV陽性がん患者の臨床結果を大幅に改善する可能性がある.
関連する概念動画
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

